{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:33:47Z","timestamp":1776299627917,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23136-2","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:15:38Z","timestamp":1762884938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mass production of IgY-containing tablets for COVID-19 transmission control"],"prefix":"10.1038","volume":"15","author":[{"given":"Michelle","family":"Hawkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Robley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhang","family":"Alem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarthi","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Hull","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Hajduk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wallach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"23136_CR1","doi-asserted-by":"crossref","unstructured":"Frumkin, L. R. et al. Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19. Front. Immunol. 13, 1\u201319 (2022).","DOI":"10.3389\/fimmu.2022.899617"},{"key":"23136_CR2","doi-asserted-by":"publisher","first-page":"9465398","DOI":"10.1155\/2020\/9465398","volume":"2020","author":"Y Lu","year":"2020","unstructured":"Lu, Y. et al. Generation of chicken IgY against SARS-COV-2 Spike protein and epitope mapping. J. Immunol. Res. 2020, 9465398 (2020).","journal-title":"J. Immunol. Res."},{"key":"23136_CR3","doi-asserted-by":"publisher","first-page":"107172","DOI":"10.1016\/j.intimp.2020.107172","volume":"90","author":"S Wei","year":"2021","unstructured":"Wei, S. et al. Chicken egg yolk antibodies (IgYs) block the binding of multiple SARS-CoV-2 Spike protein variants to human ACE2. Int. Immunopharmacol. 90, 107172 (2021).","journal-title":"Int. Immunopharmacol."},{"key":"23136_CR4","doi-asserted-by":"publisher","first-page":"954310","DOI":"10.3389\/fimmu.2022.954310","volume":"13","author":"MG Wallach","year":"2022","unstructured":"Wallach, M. G. & Opinion The use of chicken IgY in the control of pandemics. Front. Immunol. 13, 954310 (2022).","journal-title":"Front. Immunol."},{"key":"23136_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.vetimm.2007.02.001","volume":"117","author":"YC Lee","year":"2007","unstructured":"Lee, Y. C. et al. A dominant antigenic epitope on SARS-CoV Spike protein identified by an avian single-chain variable fragment (scFv)-expressing phage. Vet. Immunol. Immunopathol. 117, 75\u201385 (2007).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"23136_CR6","unstructured":"Guozhu, H. et al. Study on the effect of specific egg yolk Immunoglobulins (IgY) inhibiting SARS-CoV. Wei Sheng Wu Xue Za Zhi. 24, 123\u2013125. (2004)."},{"key":"23136_CR7","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1128\/CVI.05075-11","volume":"18","author":"MG Wallach","year":"2011","unstructured":"Wallach, M. G. et al. Cross-protection of chicken Immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice. Clin. Vaccine Immunol. 18, 1083\u20131090 (2011).","journal-title":"Clin. Vaccine Immunol."},{"key":"23136_CR8","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3390\/v14071510","volume":"14","author":"EJ Aston","year":"2022","unstructured":"Aston, E. J., Wallach, M. G., Narayanan, A., Ega\u00f1a-Labrin, S. & Gallardo, R. A. Hyperimmunized chickens produce neutralizing antibodies against SARS-CoV-2. Viruses 14, 1510 (2022).","journal-title":"Viruses"},{"key":"23136_CR9","doi-asserted-by":"publisher","first-page":"881604","DOI":"10.3389\/fimmu.2022.881604","volume":"13","author":"A Agurto-Arteaga","year":"2022","unstructured":"Agurto-Arteaga, A. et al. Preclinical assessment of IgY antibodies against Recombinant SARS-CoV-2 RBD protein for prophylaxis and Post-Infection treatment of COVID-19. Front. Immunol. 13, 881604 (2022).","journal-title":"Front. Immunol."},{"key":"23136_CR10","doi-asserted-by":"publisher","first-page":"03080","DOI":"10.7189\/jogh.12.03080","volume":"12","author":"LR Frumkin","year":"2022","unstructured":"Frumkin, L. R. et al. COVID-19 prophylaxis with Immunoglobulin Y (IgY) for the world population: the critical role that governments and non-governmental organizations can play. J. Glob Health. 12, 03080 (2022).","journal-title":"J. Glob Health"},{"key":"23136_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10806-019-09810-2","volume":"33","author":"M Fernyhough","year":"2020","unstructured":"Fernyhough, M., Nicol, C. J., van de Braak, T., Toscano, M. J. & T\u00f8nnessen, M. The ethics of laying Hen genetics. J. Agric. Environ. Ethics. 33, 15\u201336 (2020).","journal-title":"J. Agric. Environ. Ethics"},{"key":"23136_CR12","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/21645515.2018.1514224","volume":"15","author":"AT Abbas","year":"2019","unstructured":"Abbas, A. T., El-Kafrawy, S. A., Sohrab, S. S. & Azhar, E. I. A. IgY antibodies for the immunoprophylaxis and therapy of respiratory infections. Hum. Vaccin Immunother. 15, 264\u2013275 (2019).","journal-title":"Hum. Vaccin Immunother"},{"key":"23136_CR13","doi-asserted-by":"publisher","first-page":"696003","DOI":"10.3389\/fimmu.2021.696003","volume":"12","author":"L Lee","year":"2021","unstructured":"Lee, L., Samardzic, K., Wallach, M., Frumkin, L. R. & Mochly-Rosen, D. Immunoglobulin Y for potential diagnostic and therapeutic applications in infectious diseases. Front. Immunol. 12, 696003 (2021).","journal-title":"Front. Immunol."},{"key":"23136_CR14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0264-410X(95)98255-9","volume":"13","author":"M Wallach","year":"1995","unstructured":"Wallach, M. et al. Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine 13, 347\u2013354 (1995).","journal-title":"Vaccine"},{"key":"23136_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","volume":"183","author":"L Piccoli","year":"2020","unstructured":"Piccoli, L. et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 Spike Receptor-Binding domain by Structure-Guided High-Resolution serology. Cell 183, 1024\u20131042  e21. (2020).","journal-title":"Cell"},{"key":"23136_CR16","doi-asserted-by":"crossref","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell. Host Microbe 29, 463\u2013476 (2021).","DOI":"10.1016\/j.chom.2021.02.003"},{"key":"23136_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","volume":"584","author":"L Liu","year":"2020","unstructured":"Liu, L. et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 Spike. Nature 584, 450\u2013456 (2020).","journal-title":"Nature"},{"key":"23136_CR18","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","volume":"184","author":"M McCallum","year":"2021","unstructured":"McCallum, M. et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell 184, 2332\u201347e16 (2021).","journal-title":"Cell"},{"key":"23136_CR19","doi-asserted-by":"publisher","first-page":"1074077","DOI":"10.3389\/fimmu.2022.1074077","volume":"13","author":"J Li","year":"2022","unstructured":"Li, J. et al. Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects. Front. Immunol. 13, 1074077 (2022).","journal-title":"Front. Immunol."},{"key":"23136_CR20","doi-asserted-by":"crossref","unstructured":"Wongso, H. et al. Preclinical evaluation of chicken egg yolk antibody (IgY) Anti-RBD Spike SARS-CoV-2-A candidate for passive immunization against COVID-19. Vaccines (Basel) 10, 1\u201317 (2022).","DOI":"10.3390\/vaccines10010128"},{"key":"23136_CR21","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1021\/jf205319s","volume":"60","author":"N Gujral","year":"2012","unstructured":"Gujral, N., L\u00f6benberg, R., Suresh, M. & Sunwoo, H. In-Vitro and In-Vivo binding activity of chicken egg yolk Immunoglobulin Y (IgY) against Gliadin in food matrix. J. Agric. Food Chem. 60, 3166\u20133172 (2012).","journal-title":"J. Agric. Food Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23136-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23136-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:15:39Z","timestamp":1762884939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23136-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23136"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23136-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5068132\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving animals were reviewed and approved by Camas Inc. Animal Care and Use Committee. All laying hens were raised following the National Chicken Council\u2019s recommendations. All experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"39487"}}